Back
OSL
Oncosil Medical Ltd
π¦πΊ ASX
π LIFE SCIENCES TOOLS & SERVICES
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 193.05%
Annual Growth
5 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
3
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in Macquarie, New South Wales. The company went IPO on 2005-08-15. The firm is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The firm has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.
π Performance
Price History
+808.60%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$1.25
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in OSL
3
π Total Capital Earnings
$-311.843
π Average investment frequency
81 weeks
π΅ Average investment amount
$848
β° Last time a customer invested in OSL
38 days
OSL investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
67%
Less than 50k
33%
πΆ Age of investors
18 - 25
26 - 34
67%
35 - 90
33%
π Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in OSL also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
8.51%
π Share price
$110.36 AUD
π§± MATERIALS
π¦πΊ AUSTRALIA
πΈ FINANCIALS
π HIGH PRICE GROWTH
β³οΈ DIVERSIFIED
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
8.11%
π Share price
$74.70 AUD
β³οΈ DIVERSIFIED
π GLOBAL
π HIGH PRICE GROWTH
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
24.29%
π Share price
$69.85 AUD
πΊπΈ UNITED STATES
π HIGH PRICE GROWTH
LIT
Livium Ltd. engages in the production and development of lithium. The company is headquartered in Kewdale, Western Australia. The company went IPO on 2007-10-30. The firm operates battery recycler, produces critical battery material lithium ferro phosphate (LFP), and has developed patented lithium extraction technology (LieNA). Its segments include Battery Recycling, Lithium Chemicals, and Battery Materials. The Lithium Chemicals segment is developing a patented lithium extraction technology, LieNA, which is the subject of a Joint Development Agreement with Mineral Resources Limited. The Battery Materials segment is developing critical battery materials including LFP and lithium manganese ferro phosphate. The Battery Recycling segment Australiaβs market lithium-ion battery recycler. This segment provides national collection and recycling services with shredding and battery processing facilities in Melbourne. Its proprietary process involves recovery of energy metals as mixed metal dust, which is then exported for further refining.
π Performance (5Yr p.a)
-15.20%
π Share price
$0.01 AUD
π¨ COMMERCIAL SERVICES & SUPPLIES
Want more shares? Try these...